Advertisement

Header Utility Menu

  • Subscribe
  • Advertise
  • Contact Us
  • Events

LinkedIn Facebook Twitter Instagram Get Our App

  • Login

Virginia Business

Mobile Menu

  • Issues
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • Nominate a Virginia financial professional
    • Nominate A Woman in Leadership Today
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Advertisement

Header Primary Menu

  • Issues
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • Issues Archive
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • Nominate a Virginia financial professional
    • Nominate A Woman in Leadership Today
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Home News Regions Eastern Virginia Norfolk firm to use cannabidiol for medical research

Norfolk firm to use cannabidiol for medical research

Published September 28, 2018 by Joan Tupponce

Sanyal Biotechnology’s Rebecca Caffrey
Photo by Mark Rhodes

In May, Nofolk-based Sanyal Biotechnology became one of few U.S. companies to receive licensing to import cannabidiol (CBD) for medical research and clinical trials.

CBD is an oil extracted from hemp or marijuana. It also can be synthesized in a laboratory. Under the license, Sanyal also can import tetrahydrocannabinol (THC), a marijuana extract that has some medical benefits but also is the mind-altering component of cannabis. 

Sanyal, which was spun out of Virginia Commonwealth University in 2015, applied for the license after being asked by Ontario-based Revive Therapeutics to use CBD to conduct research on obesity and NASH (the most severe form of non-alcoholic fatty liver disease). “We never anticipated getting into this industry. The company found us,” says Rebecca Caffrey, Sanyal’s CEO.

Drugs falling under Schedule 1 classification of the U.S. Controlled Substances Act are illegal. They include heroin, LSD and marijuana. The federal government scrutinizes Schedule 1 licensing applications to prevent the import and sale of products for illegal purposes.

The licensing process with the Virginia Board of Pharmacy and the U.S. Drug Enforcement Agency took a year to complete. “It’s nearly impossible to get a license,” says Caffrey. “We got the broadest license available.”

Interest from researchers and physicians conducting clinical trials with CBD has increased since June when the FDA approved the drug Epidiolex, which contains pure CBD. The drug, produced by GW Pharmaceuticals, will be used to treat seizures in patients with rare, severe forms of epilepsy.  

The FDA’s decision has set up a difficult decision for the government. “This has forced the hands of the federal government,” says Caffrey. “They have to determine if they reschedule marijuana.”

The DEA has “90 days to schedule Epidiolex as a Schedule 2, 3, 4 or 5 drug or not schedule it at all. We are in the process of looking into this,” says DEA spokesman Wade Sparks. “That does not mean it will be a sweeping reschedule of CBD or marijuana as a whole. CBD could stay Schedule 1. It could come out a total reschedule of the ingredient but it doesn’t have to be. All that is being determined by the DEA.”

Caffrey is talking to physicians in other states about the potential use of CBD properties to treat attention deficit disorder, headaches, depression, anxiety, sleep disorders and post-traumatic stress disorder. “Before we couldn’t get the drugs to do clinical trials,” she says. “We are bringing a piece of the puzzle that no one has had before.”

This type of research represents a growing area in the medical field. In February, the Virginia Senate and House of Delegates passed HB 125, allowing the use of CBD oil or THC-A oil to help alleviate the symptoms of diagnosed conditions or diseases. Gov. Ralph Northam signed the bill in March.

“This is a challenging environment. Everything changes on a daily basis,” Caffrey says. “It’s like working on roller skates in a greased rink that is on fire.”

Related Stories

Virginia Business logo

Chesapeake eatery location sells for $1.8 million

ADP center will create 1,800 jobs in Norfolk

Virginia Business logo

$59.6M hydroponic operation coming to Va. Beach

One of the East Coast's largest greenhouses, it will create 155 jobs

Trending

ESPN: Snyders receive two $6B bids for Commanders

U.Va. commerce alum donates $10M for scholarships

Falling short

Atlantic Park breaks ground in Virginia Beach

Youngkin announces $8.1M in GO Virginia grants

Sponsored Stories

Remove the Mess and Stress by Moving to the Cloud

Working at Pinnacle Financial Partners

What Logistics issues will have the biggest impact on you in 2023?

In the New Year, Aim for Better Cybersecurity

Advertisement

Advertisement

Trending

ESPN: Snyders receive two $6B bids for Commanders

U.Va. commerce alum donates $10M for scholarships

Falling short

Atlantic Park breaks ground in Virginia Beach

Youngkin announces $8.1M in GO Virginia grants

Sponsored Stories

Remove the Mess and Stress by Moving to the Cloud

Working at Pinnacle Financial Partners

What Logistics issues will have the biggest impact on you in 2023?

In the New Year, Aim for Better Cybersecurity

Get Virginia Business directly on your tablet or in your mailbox!

Subscribe to Virginia Business

Advertisement

Advertisement

Footer Primary Menu

  • virginiabusiness.com
  • Subscribe
  • Advertise
  • About Us
  • Contact Us

Footer Secondary Menu

  • Industries
  • Regions
  • Reports
  • Company News
  • Events

Sign Up For Our Newsletter

Sign Up

LinkedIn Facebook Twitter Instagram Get Our App

Privacy Policy Cookie Policy

Footer Utility Menu

Copyright © 2023 Virginia Business. All rights reserved.

Site Maintained by TechArk